| [1] |
Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022 [J]. J Natl Cancer Cent, 2024, 4(1): 47-53.
|
| [2] |
Meyer ML, Fitzgerald BG, Paz-Ares L, et al. New promises and challenges in the treatment of advanced non-small-cell lung cancer[J]. Lancet, 2024, 404(10454): 803-822.
|
| [3] |
HARMONi-A Study Investigators, Fang W, Zhao Y, et al. Ivonescimab plus chemotherapy in non-small cell lung cancer with EGFR variant: a randomized clinical trial[J]. JAMA, 2024, 332(7): 561-570.
|
| [4] |
黎鹏,王敏,刘敏.二线化疗联合PD-1/PD-L1抑制剂治疗晚期非小细胞肺癌的临床疗效分析[J].中国现代药物应用, 2023, 17(22): 108-111.
|
| [5] |
周忠,陈默,井晓婷,等.重症肺炎患者Akt/NF-κB信号通路分子表达及其预后[J].中华医院感染学杂志, 2023, 33(10): 1477-1481.
|
| [6] |
任桂灵,吴小山,宋晓坤,等.替雷利珠单抗致免疫相关性肺炎的诊疗策略分析和药学监护[J].中国医院药学杂志, 2023, 43(11): 1291-1295.
|
| [7] |
赵莎莎,戴晓宇,李莉,等.脐带间充质干细胞治疗高氧新生大鼠肺损伤的研究[J].中国医药生物技术, 2025, 20(1): 73-79.
|
| [8] |
陈玮,吴梦瑶,李亚虎,等.晚期非小细胞肺癌免疫相关性肺炎影响因素及预后分析[J].中华肿瘤防治杂志, 2023, 30(20): 1223-1229.
|
| [9] |
Xu S, Deng KQ, Lu C, et al. Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects[J]. Metabolism, 2024(155): 155832.
|
| [10] |
Rizo-Téllez SA, Sekheri M, Filep JG.C-reactive protein: a target for therapy to reduce inflammation[J]. Front Immunol, 2023(14): 1237729.
|
| [11] |
Cupido G, Günther G. Post tuberculosis lung disease and tuberculosis sequelae: a narrative review[J]. Indian J Tuberc, 2024, 71(1): 64-72.
|
| [12] |
Bouchant L, Godet T, Arpajou G, et al. Physiological effects and safety of bed verticalization in patients with acute respiratory distress syndrome[J]. Crit Care, 2024, 28(1): 1-12.
|
| [13] |
Yan J, Wang SY, Su Q, et al. Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile[J]. Nat Commun, 2025, 16(1): 3748.
|
| [14] |
潘历波,薛龙梅,贾霞,等.免疫检查点抑制剂相关性肺炎的临床特点及CT表现[J].中国CT和MRI杂志, 2024, 22(2): 55-57.
|
| [15] |
郭森,朱慧志.基于网络药理学方法和分子对接技术探讨瓜蒌-薤白药对治疗胸闷变异性哮喘的作用机制[J].山西中医药大学学报, 2025, 26(1): 75-84, 91.
|
| [16] |
|
| [17] |
王天鸣,张良,程颖.非小细胞肺癌免疫相关性肺炎研究进展[J].肿瘤防治研究, 2023, 50(8): 808-812.
|
| [18] |
白文梅,李风森.基于TGF-β1/JNK信号通路探讨补肺益气通络方治疗特发性肺纤维化的作用机制[J].重庆医学, 2024, 53(16): 2401-2407, 2413.
|
| [19] |
俞颖婷,曹樟全,张洪波. IL-6/IL-10对急性呼吸窘迫综合征患者病情及预后的评估价值[J].中国现代医生, 2023, 61(9): 21-25.
|
| [20] |
孙英梅,马瑞雪,闫慧明.结缔组织病相关间质性肺病部分生物标志物的研究进展[J].风湿病与关节炎, 2023, 12(9): 76-80.
|
| [21] |
潘建亮,梁婷婷,侯建华.支气管肺泡灌洗液细胞学检查联合淋巴细胞免疫分析对卒中相关性肺炎危重患者临床疗效单中心、开放标签、随机、对照研究[J].中国免疫学杂志, 2025, 41(7): 1763-1767.
|
| [22] |
张涵,祖育娜,张华.非小细胞肺癌患者肺泡灌洗液中T淋巴细胞亚群及血清炎症因子与免疫检查点抑制剂相关性肺炎的关系[J].新乡医学院学报, 2023, 40(9): 824-828.
|
| [23] |
刘蓓蓓,李斐,彭卫卫,等.清肺排毒汤联合甲泼尼龙治疗免疫检查点抑制剂相关性肺炎患者临床观察[J].天津中医药, 2024, 41(6): 697-701.
|
| [24] |
唐浩淳,孟珺,夏铮铮.非小细胞肺癌患者免疫检查点抑制剂相关性肺炎的研究进展[J].今日药学, 2023, 33(9): 648-651.
|
| [25] |
Khalil ORS, Mallah SMA, Owda F, et al. Brentuximab-induced pneumonitis and organizing pneumonia: a case report with literiture review[J]. Ann Med Surg (Lond), 2024, 86(5): 3029-3035.
|
| [26] |
Tian Z, Chen Y, Yao Y, et al. Immunogenicity and risk factors for poor humoral immune response to SARS-CoV-2 vaccine in patients with autoimmune hepatitis: a systematic review and meta-analysis[J]. Rev Esp Enferm Dig, 2024, 116(12): 671-679.
|
| [27] |
David M, Dieude P, Debray MP, et al. Méthotrexate à faible dose: indications et effets secondaires, en particulier en cas de pneumopathie interstitielle diffuse [Low-dose methotrexate: Indications and side effects, particularly in cases of diffuse interstitial pneumonia][J]. Rev Mal Respir, 2024, 41(8): 605-619.
|
| [28] |
Moore DC, Elmes JB, Arnall JR, et al. PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: a pharmacovigilance study and systematic review[J]. Int Immunopharmacol, 2024(129): 111606.
|
| [29] |
Zhang Y, Wang P, Geng Z, et al. Geniposide attenuates influenza virus-induced pneumonia by regulating inflammatory cytokines production. evidences to elucidate the followed pathway[J]. Phytomedicine, 2024(135): 11.
|
| [30] |
Jiang L, Lunding LP, Webber WS, et al. An antibody to IL-1 receptor 7 protects mice from LPS-induced tissue and systemic inflammation[J]. Frontiers in Immunology, 2024(15): 1427100.
|
| [31] |
Matera MG, Ora J, Calzetta L, et al. Biologics for asthma and risk of pneumonia[J]. J Asthma, 2024, 61(9): 905-911.
|
| [32] |
张静涛,刘子琛,纪凌云,等.非小细胞肺癌免疫检查点抑制剂相关性肺炎研究进展及中西医结合治疗[J].中国免疫学杂志, 2024, 40(1): 213-219.
|
| [33] |
李站,吴思渊,杜欣颖,等.名中医申洪波培土肃金法辨治肺癌免疫治疗相关性肺炎[J].陕西中医, 2024, 45(6): 820-823.
|
| [34] |
Gao J, Zhang P, Tang M, et al. Predictors of immune checkpoint inhibitor-related adverse events in older patients with lung cancer: a prospective real-world analysis[J]. J Cancer Res Clin Oncol, 2023, 149(11): 8993-9006.
|
| [35] |
许炬珍,张丽卿. JAK/STAT信号通路在类风湿关节炎致病机制及治疗靶点中的作用进展[J].河北医药, 2024, 46(4): 601-605, 611.
|
| [36] |
赵洪睿.免疫检查点抑制剂治疗晚期恶性肿瘤相关免疫不良事件的Meta分析与系统评价[D].石家庄:河北医科大学, 2023.
|